Cristiana Costa Chase, Do

This study is testing whether a drug called belantamab mafodotin, combined with a steroid, can be safely given every 6 weeks in local community clinics instead of every 3 weeks at large hospitals. It focuses on patients with multiple myeloma that has returned or stopped respondin…